Is BioCryst Pharmaceuticals, Inc. technically bullish or bearish?

As of 3 October 2025, the technical trend for BioCryst Pharmaceuticals, Inc. has changed from mildly bearish to bearish. The current stance is bearish with a weak strength indicated by the weekly and monthly MACD being bearish, as well as the Bollinger Bands and daily moving averages also signaling bearish trends. The KST shows a mixed signal with a weekly bearish and monthly bullish, while Dow Theory and OBV are both mildly bearish on a weekly and monthly basis.
In terms of performance, the stock has underperformed against the S&P 500 across multiple periods, with a 1-week return of -6.29% compared to the S&P 500's 1.09%, and a 1-month return of -13.75% against the S&P 500's 4.15%. Over the past year, the stock is down -3.64% while the S&P 500 has gained 17.82%.